New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - nimodipine 30mg - film coated tablet - 30 mg - active: nimodipine 30mg excipient: crospovidone hypromellose iron oxide yellow macrogol 4000 magnesium stearate maize starch microcrystalline cellulose povidone titanium dioxide - after a preceding infusion of nimotop concentrated intravenous infusion solution, for:- prophylaxis and treatment of ischaemic neurological deficits caused by cerebral vasospasm following subarachnoid haemorrhage of aneurysmal origin. patients should be in good neurological condition post-ictus.

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - nimodipine, quantity: 0.2 mg/ml - injection, intravenous infusion - excipient ingredients: ethanol; macrogol 400; sodium citrate dihydrate; citric acid; water for injections - prophylaxis and treatment of ischaemic neurological deficits caused by cerebral vasospasm after subarachnoid haemorrhage following ruptured intracranial aneurysm, in patients who are in good neurological condition post-ictus (eg hunt and hess grades i-iii).

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - nimodipine, quantity: 30 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; maize starch; crospovidone; magnesium stearate; hypromellose; macrogol 4000; iron oxide yellow; titanium dioxide - prophylaxis and treatment of ischaemic neurological deficits caused by cerebral vasospasm after subarachnoid haemorrhage following ruptured intracranial aneurysm, in patients who are in good neurological condition post-ictus (eg hunt and hess grades i-iii).

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - nimodipine 0.2 mg/ml - solution for infusion - 0.2 mg/ml - active: nimodipine 0.2 mg/ml excipient: citric acid ethanol macrogol 400 sodium citrate dihydrate water for injection - prophylaxis and treatment of ischaemic neurological deficits caused by cerebral vasospasm following subarachnoid haemorrhage of aneurysmal origin. patients should be in good neurological condition post-ictus.

Singapore - English - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - nimodipine - tablet, film coated - 30 mg - nimodipine 30 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - nimodipine -

Malta - English - Medicines Authority

bayer plc - nimodipine - solution for infusion or injection - nimodipine 0.02 % (w/v) - calcium channel blockers

Ireland - English - HPRA (Health Products Regulatory Authority)

bayer limited - nimodipine - concentrate for solution for infusion - 0.02 percent weight/volume - dihydropyridine derivatives; nimodipine

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - nimodipine - solution for infusion - 200microgram/1ml

Malta - English - Medicines Authority

bayer limited 1st floor the grange offices the grange brewery road stillorgan co. dublin, a94 h2k7 , ireland - nimodipine - concentrate for solution for infusion - nimodipine 0.2 mg/ml - calcium channel blockers